Correlation Between West Pharmaceutical and NeuroMetrix

Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and NeuroMetrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and NeuroMetrix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between West Pharmaceutical Services and NeuroMetrix, you can compare the effects of market volatilities on West Pharmaceutical and NeuroMetrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of NeuroMetrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and NeuroMetrix.

Diversification Opportunities for West Pharmaceutical and NeuroMetrix

-0.5

Correlation Coefficient

West Pharmaceutical  NeuroMetrix

Very good diversification

The 3 months correlation between West and NeuroMetrix is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and NeuroMetrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroMetrix and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with NeuroMetrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroMetrix has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and NeuroMetrix go up and down completely randomly.

Pair Corralation between West Pharmaceutical and NeuroMetrix

Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.84 times more return on investment than NeuroMetrix. However, West Pharmaceutical Services is 1.19 times less risky than NeuroMetrix. It trades about 0.05 of its potential returns per unit of risk. NeuroMetrix is currently generating about 0.04 per unit of risk. If you would invest  30,011  in West Pharmaceutical Services on September 5, 2024 and sell it today you would earn a total of  2,178  from holding West Pharmaceutical Services or generate 7.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

West Pharmaceutical Services  vs.  NeuroMetrix

West Pharmaceutical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

NeuroMetrix

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroMetrix are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, NeuroMetrix may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with West Pharmaceutical and NeuroMetrix

The main advantage of trading using opposite West Pharmaceutical and NeuroMetrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, NeuroMetrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will offset losses from the drop in NeuroMetrix's long position.

The idea behind West Pharmaceutical Services and NeuroMetrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.